🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Abbott Labs Earnings, Revenue beat in Q1

Published 2019-04-17, 07:49 a/m
© Reuters.
US500
-
ABT
-

Investing.com - Abbott Labs (NYSE:ABT) reported first quarter earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts.

The firm reported earnings per share of $0.63 on revenue of $7.54B. Analysts polled by Investing.com anticipated EPS of $0.61 on revenue of $7.47B. That compared to EPS of $0.59 on revenue of $7.39B in the same period a year earlier. The company had reported EPS of $0.81 on revenue of $7.77B in the previous quarter.

Abbott Labs shares gained 0.55% to trade at $76.80 in pre-market trade following the report.

For the year, Abbott Labs shares are up 5.6%, under-performing the S&P 500 which is up 17.36% year to date.

Abbott Labs follows other major Healthcare sector earnings this month


On Tuesday, J&J reported first quarter EPS of $2.1 on revenue of $20.02B, compared to forecasts of EPS of $2.04 on revenue of $19.62B.

LivaNova PLC earnings missed analyst's expectations on Wednesday, February 27, 2019, with fourth quarter EPS of $0.95 on revenue of $297M. Investing.com analysts expected EPS of $1.1 on revenue of $294.99M

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.